They further found that granzyme C-expressing ILC1s expanded in mammary tumors and can mediate anti-tumor responses, a mechanism dependent on transforming growth factor beta (TGF-β) and IL-15 signaling [45]. This evidence concerns the gene IL15 and neoplasm.